Recoverin

a Potent Uveitogen for the Induction of Photoreceptor Degeneration in Lewis Rats

Grazyna Adamus, Henry Ortega, Danuta Witkowska, Arthur Polans

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Recoverin is a calcium-binding protein identified as an autoantigen in a paraneoplastic degenerative disease of the human retina known as cancer-associated retinopathy (CAR). In this study we investigated whether recoverin could elicit an immune response leading to the degeneration of photoreceptor cells in a rodent retina, and whether an animal model of CAR could be developed. Injection of Lewis rats with recoverin caused degeneration of the photoreceptor cells. Several features of uveoretinitis were observed, including vitreous cells, perivasculitis, retinal lesions and complete loss of the photoreceptor cell layer. The first clinical signs of retinal inflammation were observed 10-14 days after immunization. The earliest histological changes in the retina also were observed 14 days after immunization. Infiltration of the photoreceptor cell layer and inner layers of the retina with lymphocytic and some polymorphonuclear cells was frequently observed. Photoreceptors were damaged and later fully degenerated. This sequence of events was associated with high antibody titers against recoverin in all animals tested. Cellular responses to recoverin assayed between days 7 and 28 after immunization showed strong in vitro proliferative activities to recoverin. In addition, all aspects of the degenerative events could be reproduced in naive animals by the adoptive transfer of stimulated lymphocytes obtained from animals previously immunized with recoverin. This study demonstrates the successful induction of photoreceptor degeneration using recoverin as an immunogen. We demonstrate that recoverin is both a potent antigen and uveitogen. These observations may be relevant to our understanding of CARs in humans.

Original languageEnglish (US)
Pages (from-to)447-456
Number of pages10
JournalExperimental Eye Research
Volume59
Issue number4
DOIs
StatePublished - Oct 1994

Fingerprint

Recoverin
Photoreceptor Cells
Retina
Ocular Paraneoplastic Syndromes
Immunization
Calcium-Binding Proteins
Adoptive Transfer
Autoantigens
Rodentia
Animal Models
Lymphocytes

Keywords

  • cancer-associated retinopathy
  • CAR antigen
  • photoreceptor
  • recoverin
  • retina
  • uveitis

ASJC Scopus subject areas

  • Sensory Systems
  • Ophthalmology

Cite this

Recoverin : a Potent Uveitogen for the Induction of Photoreceptor Degeneration in Lewis Rats. / Adamus, Grazyna; Ortega, Henry; Witkowska, Danuta; Polans, Arthur.

In: Experimental Eye Research, Vol. 59, No. 4, 10.1994, p. 447-456.

Research output: Contribution to journalArticle

Adamus, Grazyna ; Ortega, Henry ; Witkowska, Danuta ; Polans, Arthur. / Recoverin : a Potent Uveitogen for the Induction of Photoreceptor Degeneration in Lewis Rats. In: Experimental Eye Research. 1994 ; Vol. 59, No. 4. pp. 447-456.
@article{c0337dcc9d0448f19b62f30cb7480727,
title = "Recoverin: a Potent Uveitogen for the Induction of Photoreceptor Degeneration in Lewis Rats",
abstract = "Recoverin is a calcium-binding protein identified as an autoantigen in a paraneoplastic degenerative disease of the human retina known as cancer-associated retinopathy (CAR). In this study we investigated whether recoverin could elicit an immune response leading to the degeneration of photoreceptor cells in a rodent retina, and whether an animal model of CAR could be developed. Injection of Lewis rats with recoverin caused degeneration of the photoreceptor cells. Several features of uveoretinitis were observed, including vitreous cells, perivasculitis, retinal lesions and complete loss of the photoreceptor cell layer. The first clinical signs of retinal inflammation were observed 10-14 days after immunization. The earliest histological changes in the retina also were observed 14 days after immunization. Infiltration of the photoreceptor cell layer and inner layers of the retina with lymphocytic and some polymorphonuclear cells was frequently observed. Photoreceptors were damaged and later fully degenerated. This sequence of events was associated with high antibody titers against recoverin in all animals tested. Cellular responses to recoverin assayed between days 7 and 28 after immunization showed strong in vitro proliferative activities to recoverin. In addition, all aspects of the degenerative events could be reproduced in naive animals by the adoptive transfer of stimulated lymphocytes obtained from animals previously immunized with recoverin. This study demonstrates the successful induction of photoreceptor degeneration using recoverin as an immunogen. We demonstrate that recoverin is both a potent antigen and uveitogen. These observations may be relevant to our understanding of CARs in humans.",
keywords = "cancer-associated retinopathy, CAR antigen, photoreceptor, recoverin, retina, uveitis",
author = "Grazyna Adamus and Henry Ortega and Danuta Witkowska and Arthur Polans",
year = "1994",
month = "10",
doi = "10.1006/exer.1994.1130",
language = "English (US)",
volume = "59",
pages = "447--456",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Recoverin

T2 - a Potent Uveitogen for the Induction of Photoreceptor Degeneration in Lewis Rats

AU - Adamus, Grazyna

AU - Ortega, Henry

AU - Witkowska, Danuta

AU - Polans, Arthur

PY - 1994/10

Y1 - 1994/10

N2 - Recoverin is a calcium-binding protein identified as an autoantigen in a paraneoplastic degenerative disease of the human retina known as cancer-associated retinopathy (CAR). In this study we investigated whether recoverin could elicit an immune response leading to the degeneration of photoreceptor cells in a rodent retina, and whether an animal model of CAR could be developed. Injection of Lewis rats with recoverin caused degeneration of the photoreceptor cells. Several features of uveoretinitis were observed, including vitreous cells, perivasculitis, retinal lesions and complete loss of the photoreceptor cell layer. The first clinical signs of retinal inflammation were observed 10-14 days after immunization. The earliest histological changes in the retina also were observed 14 days after immunization. Infiltration of the photoreceptor cell layer and inner layers of the retina with lymphocytic and some polymorphonuclear cells was frequently observed. Photoreceptors were damaged and later fully degenerated. This sequence of events was associated with high antibody titers against recoverin in all animals tested. Cellular responses to recoverin assayed between days 7 and 28 after immunization showed strong in vitro proliferative activities to recoverin. In addition, all aspects of the degenerative events could be reproduced in naive animals by the adoptive transfer of stimulated lymphocytes obtained from animals previously immunized with recoverin. This study demonstrates the successful induction of photoreceptor degeneration using recoverin as an immunogen. We demonstrate that recoverin is both a potent antigen and uveitogen. These observations may be relevant to our understanding of CARs in humans.

AB - Recoverin is a calcium-binding protein identified as an autoantigen in a paraneoplastic degenerative disease of the human retina known as cancer-associated retinopathy (CAR). In this study we investigated whether recoverin could elicit an immune response leading to the degeneration of photoreceptor cells in a rodent retina, and whether an animal model of CAR could be developed. Injection of Lewis rats with recoverin caused degeneration of the photoreceptor cells. Several features of uveoretinitis were observed, including vitreous cells, perivasculitis, retinal lesions and complete loss of the photoreceptor cell layer. The first clinical signs of retinal inflammation were observed 10-14 days after immunization. The earliest histological changes in the retina also were observed 14 days after immunization. Infiltration of the photoreceptor cell layer and inner layers of the retina with lymphocytic and some polymorphonuclear cells was frequently observed. Photoreceptors were damaged and later fully degenerated. This sequence of events was associated with high antibody titers against recoverin in all animals tested. Cellular responses to recoverin assayed between days 7 and 28 after immunization showed strong in vitro proliferative activities to recoverin. In addition, all aspects of the degenerative events could be reproduced in naive animals by the adoptive transfer of stimulated lymphocytes obtained from animals previously immunized with recoverin. This study demonstrates the successful induction of photoreceptor degeneration using recoverin as an immunogen. We demonstrate that recoverin is both a potent antigen and uveitogen. These observations may be relevant to our understanding of CARs in humans.

KW - cancer-associated retinopathy

KW - CAR antigen

KW - photoreceptor

KW - recoverin

KW - retina

KW - uveitis

UR - http://www.scopus.com/inward/record.url?scp=0028096770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028096770&partnerID=8YFLogxK

U2 - 10.1006/exer.1994.1130

DO - 10.1006/exer.1994.1130

M3 - Article

VL - 59

SP - 447

EP - 456

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

IS - 4

ER -